logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10772917 B1

PDFFull Text
Date of Patent:
Sep. 15, 2020

Filed:

Mar. 11, 2016

Pancreatic endocrine progenitor cell therapies for the treatment of obesity and type 2 diabetes (t2d)

Applicant:

The University of British Columbia, Vancouver, British Columbia, CA;

Inventors:

Timothy J. Kieffer, Vancouver, CA;

Jennifer E. Bruin, Vancouver, CA;

Assignee:

CCS VENTURES LIMITED, Vancouver, B.C., CA;

Attorneys:

Bozicevic, Field & Francis LLP

Shweta Chandra

Primary Examiner:

Thomas J Visone

Int. Cl.
CPC ...
A61K 35/39 (2015.01); A61K 31/155 (2006.01); A61K 31/4439 (2006.01); A61K 31/4985 (2006.01); A61K 45/06 (2006.01); C12N 5/071 (2010.01);
U.S. Cl.
CPC ...
A61K 35/39 (2013.01); A61K 31/155 (2013.01); A61K 31/4439 (2013.01); A61K 31/4985 (2013.01); A61K 45/06 (2013.01); C12N 5/0677 (2013.01);
Abstract

Provided herein are therapies, and methods using that therapy, in the treatment of one or more of Type 2 diabetes (T2D), obesity, glucose intolerance and insulin resistance or to control weight gain in subjects. In particular, the subject may be candidates for treatment with one or more small molecule anti-diabetic drugs and the therapy may include implanting a population of pancreatic endocrine progenitor cells into the subject, where the cells are allowed to mature in vivo to produce a population.

Find Patent Forward Citations

Kieffer, Timothy. (2020). Pancreatic endocrine progenitor cell therapies for the treatment of obesity and type 2 diabetes (t2d) (U.S. Patent No. 10772917). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10772917

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…